Skip to main content
. Author manuscript; available in PMC: 2016 Mar 11.
Published in final edited form as: Cytotherapy. 2012 Aug 17;14(9):1131–1143. doi: 10.3109/14653249.2012.700767

Table III.

Characteristics of large-scale clinical-grade NK cell products expanded in G-Rex vessels.

Validation 1, healthy donor Validation 2, healthy donor Clinical product, MM patient Clinical product, healthy haplo-identical donor
% viable cells (7-AAD) 72.4 86.4 82.9 90.8
% CD3+ CD56 pre-T-cell depletion 34.1 18.7 3.5 8.1
% CD3+ CD56 post-T-cell depletion 1 0.04 n/a 0.7
% CD19+ 0.56 0.56 1.98 1.24
% CD14+ 0.09 0.05 0.24 0.05